Survey finds that Willingness to Deprescribe is Linked to Health Outcome Priorities
Green AR, Aschmann H, Boyd CM, Schoenborn N. Association between willingness to deprescribe and health outcome priorities among U.S. older adults: Results of a national
All about Outcomes: USDeN Panel Weighs in on Defining, Selecting, and Applying Deprescribing Intervention Outcomes
Bayliss, EA, Albers, K, Gleason, K, et al. Recommendations for outcome measurement for deprescribing intervention studies. J Am Geriatr Soc. 2022; 1- 11. doi:10.1111/jgs.17894 The
Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial
Elizabeth Bayliss, MD, MSPHSenior Investigator, Institute for Health Research, Kaiser Permanente ColoradoProfessor of Family Medicine, University of Colorado School of MedicineIMPACT Health Care Systems (HCS)
USDeN Call for Pilot Studies Preparatory to Large Clinical Trials
Complementary and Integrative Health Interventions to Support Deprescribing of Benzodiazepine Receptor Agonists in Older Adults The US Deprescribing Research Network (USDeN) will soon be seeking
Describing deprescribing: How do GPs discuss deprescribing topics with their patients, and how in-depth do they go?
Thompson W, Jarbøl D, Nielsen JB, Haastrup P, Pedersen LB. GP preferences for discussing statin deprescribing: a discrete choice experiment. Fam Pract. 2022;39(1):26-31. doi:10.1093/fampra/cmab075 Although
New Cohort of Junior Investigators Selected!
We are thrilled to announce our 2022-2023 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning opportunities
Beyond Study Design and Primary Outcomes: Lessons Learned from a Deprescribing Trial to Increase Cognitive Reserve
Presenter: Dr. Daniela Moga is an Associate Professor and Larry H. Spears Endowed Chair in Pharmacogenetics in the College of Pharmacy at University of Kentucky.
How can we apply pharmacoepidemiology methods to deprescribing research questions?
Moriarty F, Thompson W, Boland F. Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data. Res Social Adm
The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial
McDonald EG, Wu PE, Rashidi B, et al. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial [published
Deprescribing and Delirium, Co-hosted by USDeN and NIDUS
Presenter: Noll. L. Campbell, PharmD, MS, Assistant Professor of Pharmacy Practice at Purdue University College of Pharmacy Moderator: Sharon K. Inouye, MD, MPH, Professor of Medicine, Director of
